226 related articles for article (PubMed ID: 23305084)
21. Human platelets pathogen reduced with riboflavin and ultraviolet light do not cause acute lung injury in a two-event SCID mouse model.
Chi X; Zhi L; Vostal JG
Transfusion; 2014 Jan; 54(1):74-85. PubMed ID: 23656563
[TBL] [Abstract][Full Text] [Related]
22. Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution.
Ignatova AA; Karpova OV; Trakhtman PE; Rumiantsev SA; Panteleev MA
Vox Sang; 2016 Apr; 110(3):244-52. PubMed ID: 26646605
[TBL] [Abstract][Full Text] [Related]
23. Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment.
Schubert P; Coupland D; Culibrk B; Goodrich RP; Devine DV
Transfusion; 2013 Dec; 53(12):3164-73. PubMed ID: 23521225
[TBL] [Abstract][Full Text] [Related]
24. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
Apelseth TØ; Bruserud Ø; Wentzel-Larsen T; Bakken AM; Bjørsvik S; Hervig T
Transfusion; 2007 Apr; 47(4):653-65. PubMed ID: 17381624
[TBL] [Abstract][Full Text] [Related]
25. Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage.
Li J; Goodrich L; Hansen E; Edrich R; Gampp D; Goodrich RP
Transfusion; 2005 Nov; 45(11):1750-8. PubMed ID: 16271100
[TBL] [Abstract][Full Text] [Related]
26. Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS+ apheresis platelets.
Mastroianni MA; Llohn AH; Akkök ÇA; Skogheim R; Ødegaard ER; Nybruket MJ; Flesland A; Mousavi SA
Transfus Apher Sci; 2013 Oct; 49(2):285-90. PubMed ID: 23820429
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of extracellular vesicles derived from platelet concentrates treated with Mirasol® identifies biomarkers of platelet storage lesion.
Hermida-Nogueira L; Barrachina MN; Izquierdo I; García-Vence M; Lacerenza S; Bravo S; Castrillo A; García Á
J Proteomics; 2020 Jan; 210():103529. PubMed ID: 31605789
[TBL] [Abstract][Full Text] [Related]
28. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution.
Picker SM; Tauszig ME; Gathof BS
Transfusion; 2012 Mar; 52(3):510-6. PubMed ID: 21981030
[TBL] [Abstract][Full Text] [Related]
29. In vitro function of platelets treated with ultraviolet C light for pathogen inactivation: a comparative study with nonirradiated and gamma-irradiated platelets.
Tynngård N; Trinks M; Berlin G
Transfusion; 2015 Jun; 55(6):1169-77. PubMed ID: 25524519
[TBL] [Abstract][Full Text] [Related]
30. Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres.
van der Meer PF; Couture C; Hervig T; Kruit G; Devine DV; de Korte D; Kerkhoffs JL
Vox Sang; 2017 Jan; 112(1):9-17. PubMed ID: 28001293
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
Tonnetti L; Proctor MC; Reddy HL; Goodrich RP; Leiby DA
Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
[TBL] [Abstract][Full Text] [Related]
32. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Bu D; Bhakta V; Sheffield WP; Goodrich RP; Devine DV
Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
[TBL] [Abstract][Full Text] [Related]
33. Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage.
Apelseth TO; Hervig TA; Wentzel-Larsen T; Bruserud O
Transfusion; 2006 May; 46(5):800-10. PubMed ID: 16686848
[TBL] [Abstract][Full Text] [Related]
34. Proteome changes in platelets after pathogen inactivation--an interlaboratory consensus.
Prudent M; D'Alessandro A; Cazenave JP; Devine DV; Gachet C; Greinacher A; Lion N; Schubert P; Steil L; Thiele T; Tissot JD; Völker U; Zolla L
Transfus Med Rev; 2014 Apr; 28(2):72-83. PubMed ID: 24685438
[TBL] [Abstract][Full Text] [Related]
35. Effects of riboflavin and ultraviolet light treatment on platelet thrombus formation and thrombus stability on collagen.
Terada C; Shiba M; Nagai T; Satake M
Transfusion; 2017 Jul; 57(7):1772-1780. PubMed ID: 28417457
[TBL] [Abstract][Full Text] [Related]
36. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction.
Picker SM; Oustianskaia L; Schneider V; Gathof BS
Vox Sang; 2009 Jul; 97(1):26-33. PubMed ID: 19302416
[TBL] [Abstract][Full Text] [Related]
37. Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling.
Reid S; Johnson L; Woodland N; Marks DC
Transfusion; 2012 Oct; 52(10):2094-103. PubMed ID: 22320126
[TBL] [Abstract][Full Text] [Related]
38. In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology.
Ostrowski SR; Bochsen L; Salado-Jimena JA; Ullum H; Reynaerts I; Goodrich RP; Johansson PI
Transfusion; 2010 Oct; 50(10):2210-9. PubMed ID: 20456708
[TBL] [Abstract][Full Text] [Related]
39. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment.
Chen Z; Schubert P; Culibrk B; Devine DV
Transfusion; 2015 Apr; 55(4):848-57. PubMed ID: 25385501
[TBL] [Abstract][Full Text] [Related]
40. Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.
Ostrowski SR; Bochsen L; Windeløv NA; Salado-Jimena JA; Reynaerts I; Goodrich RP; Johansson PI
Transfusion; 2011 Feb; 51(2):344-56. PubMed ID: 20723169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
